OncWeekly Content Page - Page 35

Colorectal Cancer,Gastrointestinal Cancer

Nivolumab Plus Low-Dose Ipilimumab as First-Line Treatment for mCRC

Jun 01, 2023

Colorectal Cancer,Gastrointestinal Cancer

Evaluating the Efficacy of GDC-6036 in Advanced Solid Tumors with KRAS G12C Mutation

Jun 01, 2023

Colorectal Cancer,Gastrointestinal Cancer

Botensilimab Plus Balstilimab in Heavily Pretreated MSS CRC: Phase 1A/1B Results

Jun 01, 2023

Colorectal Cancer,Gastrointestinal Cancer

High-Dose Vitamin C + FOLFOX ± Bevacizumab v FOLFOX ± Bevacizumab in mCRC Evaluated

May 24, 2023

Advertisement

Colorectal Cancer,Gastrointestinal Cancer

Fruquintinib Effectiveness in Third-line mCC Compared to Other Targeted Kinase Inhibitors

May 22, 2023

Esophageal Cancer,Gastrointestinal Cancer

Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced Esophageal Cancer

May 02, 2023

Esophageal Cancer,Gastrointestinal Cancer

A Cost-Effectiveness Analysis on Pembrolizumab +Chemo vs. Chemo Alone for Advanced Esophageal Cancer

Apr 28, 2023

Gastrointestinal Cancer,Liver Cancer

KEYNOTE-240 Trail Assessed Pembrolizumab in Patients with Advanced Liver Cancer

Apr 21, 2023

Previous
1
…
33
34
35
36
37
…
40
Next

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Newsletter

Advertisement